Two Sigma Investments
TNXP icon

Two Sigma Investments’s Tonix Pharmaceuticals TNXP Stock Holding History

Two Sigma Investments’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,008
Closed -$66.2K – 3490
2024
Q4 		$66.2K Buy
+2,008
New +$41.7K ﹤0.01% 3018
2023
Q3 		– Sell
-4
Closed -$20.1K – 3219
2023
Q2 		$20.1K Buy
4
+1
+33% +$7.58K ﹤0.01% 2906
2023
Q1 		$35.6K Buy
3
+2
+200% +$34.3K ﹤0.01% 2797
2022
Q4 		$8.26K Sell
1
-9
-90% -$77.7K ﹤0.01% 2738
2022
Q3 		$108K Buy
+10
New +$245K ﹤0.01% 2221
2021
Q4 		– Hold
0
– -$13K – 4897
2021
Q3 		– Hold
0
– – – 4173
2018
Q4 		– Hold
0
– -$14K – 3525
2018
Q3 		– Hold
0
– – – 3116

Other funds holding TNXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CIBC Asset Management
CIBC Asset Management Toronto, Ontario, Canada $40.9B AUM 35.96% 1-Year Est. Return

Two Sigma Investments's TNXP Position: Q1 2025 in Review

Two Sigma Investments sold out of Tonix Pharmaceuticals (TNXP) in Q1 2025, closing a stake of 2,008 shares — an estimated $66.2K sold.

Two Sigma Investments first reported a position in TNXP in Q3 2022 and held it in 5 quarters. The position peaked at $108K in Q3 2022. 26 funds tracked by Wall St. Rank hold TNXP as of Q1 2025.

  • Two Sigma Investments reported no remaining Tonix Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Investments sold 2,008 Tonix Pharmaceuticals shares in Q1 2025, an estimated $66.2K.
  • Two Sigma Investments first reported a position in Tonix Pharmaceuticals in Q3 2022 and held it in 5 quarters.
  • Two Sigma Investments's Tonix Pharmaceuticals position peaked at $108K in Q3 2022.
  • 26 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q1 2025.

Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.